[
  {
    "ts": "2026-01-02T14:44:02+00:00",
    "headline": "Viatris Inc. (VTRS) Provides Updates on Four Recent Regulatory Milestones",
    "summary": "Viatris Inc. (NASDAQ:VTRS) is one of the top cheap stocks under $20 to buy now. On December 18, Viatris Inc. (NASDAQ:VTRS) announced four recent regulatory milestones spread across all stages of the company’s global pipeline. It stated that the FDA approved the company’s octreotide acetate for injectable suspension, which is a generic version of Sandostatin® […]",
    "url": "https://finance.yahoo.com/news/viatris-inc-vtrs-provides-updates-144402192.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "ef0ceb1d-3622-39ce-b1a8-8f640f74b0b3",
      "content": {
        "id": "ef0ceb1d-3622-39ce-b1a8-8f640f74b0b3",
        "contentType": "STORY",
        "title": "Viatris Inc. (VTRS) Provides Updates on Four Recent Regulatory Milestones",
        "description": "",
        "summary": "Viatris Inc. (NASDAQ:VTRS) is one of the top cheap stocks under $20 to buy now. On December 18, Viatris Inc. (NASDAQ:VTRS) announced four recent regulatory milestones spread across all stages of the company’s global pipeline. It stated that the FDA approved the company’s octreotide acetate for injectable suspension, which is a generic version of Sandostatin® […]",
        "pubDate": "2026-01-02T14:44:02Z",
        "displayTime": "2026-01-02T14:44:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/74fb705bb9c3ce561b1e73c01a8c0ec6",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Barclays Initiates Viatris (VTRS) with Overweight as Pharma Sentiment Improves",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zGSUgQWY1mvU5iiUFvOJaw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/74fb705bb9c3ce561b1e73c01a8c0ec6.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pOwRcCLvUVYudHrb3ECDAQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/74fb705bb9c3ce561b1e73c01a8c0ec6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/viatris-inc-vtrs-provides-updates-144402192.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/viatris-inc-vtrs-provides-updates-144402192.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VTRS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]